Risks of electrocardiographic left ventricular hypertrophy in hypertensive individuals and benefits of treatment-induced regression
Gene Regulatory Networks
Receptors, Metabotropic Glutamate
Left ventricular hypertrophy (LVH), a common complication of hypertension, is an important risk factor for cardiovascular disease. Patients with LVH are at a markedly increased risk for many cardiovascular complications and death. This heightened risk can be mitigated in part by antihypertensive therapy-induced regression of LVH. The electrocardiogram (ECG) is a valuable modality in the identification, risk stratification, and longitudinal follow-up of patients with hypertension and LVH. This article details the prognostic significance of ECG LVH and the benefits associated with treatment-induced LVH regression. © 2009 Current Medicine Group, LLC.
Digital Object Identifier (DOI)
Additional Document Info
has global citation frequency